Recent Advances in Targeting CD8 T-Cell Immunity for More Effective Cancer Immunotherapy.
about
Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios may aid in identifying patients with non-small cell lung cancer and predicting Tumor-Node-Metastasis stages.Complement as a Biological Tool to Control Tumor GrowthMulti-Omics Profiling of the Tumor Microenvironment: Paving the Way to Precision Immuno-OncologyTurn Back the TIMe: Targeting Tumor Infiltrating Myeloid Cells to Revert Cancer Progression
P2860
Recent Advances in Targeting CD8 T-Cell Immunity for More Effective Cancer Immunotherapy.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Recent Advances in Targeting CD8 T-Cell Immunity for More Effective Cancer Immunotherapy.
@en
Recent Advances in Targeting CD8 T-Cell Immunity for More Effective Cancer Immunotherapy.
@nl
type
label
Recent Advances in Targeting CD8 T-Cell Immunity for More Effective Cancer Immunotherapy.
@en
Recent Advances in Targeting CD8 T-Cell Immunity for More Effective Cancer Immunotherapy.
@nl
prefLabel
Recent Advances in Targeting CD8 T-Cell Immunity for More Effective Cancer Immunotherapy.
@en
Recent Advances in Targeting CD8 T-Cell Immunity for More Effective Cancer Immunotherapy.
@nl
P2093
P2860
P921
P356
P1476
Recent Advances in Targeting CD8 T-Cell Immunity for More Effective Cancer Immunotherapy
@en
P2093
Aurélie Durgeau
Fathia Mami-Chouaib
Yasemin Virk
P2860
P356
10.3389/FIMMU.2018.00014
P5008
P577
2018-01-22T00:00:00Z